Revelation Biosciences Inc (REVB NASDAQ) stock market data APIs
$2.8449
-0.08(-2.8%)
as of July 10, 2025
Try our APIs with
free plan!
Revelation Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Prev. Close
2.8449
Open
2.7675
High
2.8962
Low
2.6666
52 wk Range
2.106-102.72
Market Cap
13 006 K
Shares Outstanding
4 604 K
EPS
-2.11
Beta
-0.089
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Revelation Biosciences Inc data using free add-ons & libraries
Get Revelation Biosciences Inc Fundamental Data
Revelation Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -8 139 076
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: -6.88
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Revelation Biosciences Inc News
New
Revelation Biosciences announces 1-for-3 reverse stock split
* Revelation Biosciences (NASDAQ:REVB [https://seekingalpha.com/symbol/REVB]) announced on Tuesday that the company will implement a 1-for-3 reverse split of its common stock on July 7, 2025. * Th...
London stocks slip as Middle East tensions persist; BoE in focus
(Reuters) -London stocks slipped on Thursday as a raging conflict in the Middle East kept investors on edge ahead of the Bank of England’s monetary policy decision. The benchmark FTSE 100 was down ...
FTSE 100 today: BoE rate decision looms; Vodafone names CFO; Whitbread reports
Investing.com -- British stocks opened lower on Thursday as investors looked ahead to the Bank of England’s rate decision, with markets broadly anticipating no change in interest rates at the meetin...
European stocks fall on fears of Middle East escalation; central banks in focus
Investing.com - European stocks fell Thursday, with speculation of U.S. intervention in the Middle East keeping investors cautious ahead of a series of central bank meetings. At 03:15 ET (07:15 GMT),...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
